Daniela Marotto

ORCID: 0000-0003-3255-3307
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammasome and immune disorders
  • Rheumatoid Arthritis Research and Therapies
  • COVID-19 Clinical Research Studies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • SARS-CoV-2 and COVID-19 Research
  • Cannabis and Cannabinoid Research
  • Autoimmune and Inflammatory Disorders Research
  • Long-Term Effects of COVID-19
  • Autoimmune and Inflammatory Disorders
  • Spondyloarthritis Studies and Treatments
  • Inflammatory Myopathies and Dermatomyositis
  • Biosimilars and Bioanalytical Methods
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Skin Diseases and Diabetes
  • IL-33, ST2, and ILC Pathways
  • Sleep and Wakefulness Research
  • Atherosclerosis and Cardiovascular Diseases
  • Urticaria and Related Conditions
  • Lymphoma Diagnosis and Treatment
  • COVID-19 diagnosis using AI
  • Systemic Sclerosis and Related Diseases
  • Inflammatory Bowel Disease
  • Glycogen Storage Diseases and Myoclonus
  • Medication Adherence and Compliance

Società Italiana di Reumatologia
2023

ATS Sardegna (Italy)
2020-2022

University of Milan
2020-2021

ASST Fatebenefratelli Sacco
2020-2021

CTO Hospital
2019

University of Sassari
2008-2011

To provide a rationale for anti-IL-1 treatment in pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) by defining whether IL-1β secretion is enhanced; requires NLRP3; correlates with proline-serine-threonine phosphatase-interacting protein 1 mutations, disease activity and/or the clinical picture PAPA.Monocytes were isolated from 13 patients 35 healthy donors studied at baseline following activation. Secretion pattern of IL-1β, IL-1α, IL-1Ra, IL-6, IL-18 TNF-α was assessed...

10.1093/rheumatology/kew031 article EN Lara D. Veeken 2016-03-17

The chest computed tomography (CT) characteristics of coronavirus disease 2019 (COVID-19) are important for diagnostic and prognostic purposes. aim this study was to investigate CT findings in COVID-19 patients order determine the optimal cut-off value a severity score that can be considered potential indicator severe/critical outcome.The were evaluated by means included extent (0-4 grading scale) nature abnormalities. images at 3 levels bilaterally. A receiver operating (ROC) curve used...

10.1097/md.0000000000022433 article EN cc-by-nc Medicine 2020-10-14

BACKGROUND AND AIM To evaluate the convergent and discriminative validity of many continuous composite disease activity indices patient-reported outcome measures (PROMs) in rheumatoid arthritis (RA). METHODS In consecutive RA patients moderate or high activity, according to Simplified Disease Activity Index (SDAI) definition, were computed four additional indices, 28-joint Score - erythrocyte sedimentation rate (DAS28-ESR), Clinical (CDAI), Chronic Arthritis Systemic (CASI), Mean Overall for...

10.23750/abm.v92i4.10831 article EN Acta bio-medica : Atenei Parmensis 2021-09-02

Objective: To estimate the prevalence of rheumatoid arthritis in an Italian general population. Methods: The study was conducted years 2002-2003 Tempio Pausania’s health district located on North Sardinia and involved 30264 subjects aged 18 or more treated by 29 practices (GP). GP contact first phone letter secondly a Rheumatologist administered structured interview that included screening questionnaire for RA. Cases were defined 1987 American College rheumatology criteria adapted to...

10.4081/reumatismo.2005.273 article EN cc-by-nc Reumatismo 2011-09-12

Abstract Introduction The use of Janus Kinase Inhibitors (JAK-Is) in rheumatoid arthritis (RA) has entered daily practice. In consideration ORAL-Surveillance trial and the new EULAR recommendations, real-world data are needed to assess Jak-Is safety effectiveness. multicenter study presented here aimed evaluate effectiveness tofacitinib a real-life cohort. Methods A retrospective analysis was performed from September 2021 December 2022. Data were collected when started (T0) after 3 (T3), 6...

10.1007/s10067-023-06836-w article EN cc-by Clinical Rheumatology 2023-12-23
Coming Soon ...